Literature DB >> 10931147

Dysregulation in IL-12 secretion by neutrophils from HIV-infected patients.

A Vecchiarelli1, C Monari, B Palazzetti, F Bistoni, A Casadevall.   

Abstract

It is generally believed that neutrophils from HIV-infected patients are functionally competent, but several studies have shown impairment in neutrophil fungal killing and cytokine production. In this study we evaluated the ability of neutrophils from healthy donors and HIV-infected patients to produce IL-12 in response to stimulation with Candida albicans, lipopolysaccharide (LPS) and Cryptococcus neoformans (acapsular and encapsulated), with and without MoAb opsonization. Neutrophils from healthy donors secreted IL-12 in response to LPS or C. albicans but not in response to encapsulated or acapsular C. neoformans, regardless of MoAb opsonization. Surprisingly, neutrophils from HIV-infected patients demonstrated constitutive IL-12 production, although these cells were not responsive to LPS stimulation. The inability of MoAb to C. neoformans capsular polysaccharide to promote IL-12 production by neutrophils excludes phagocytosis and/or CD16 cross-linking in this process, and distinguishes neutrophils from monocytes. Our results provide additional evidence for cytokine dysregulation in neutrophils from HIV-infected patients. Furthermore, the IL-12 response of neutrophils and monocytes to CD16 stimulation appears to be different, suggesting differences in the role of these phagocytic cells during the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931147      PMCID: PMC1905687          DOI: 10.1046/j.1365-2249.2000.01278.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Inhibition of candidacidal activity of polymorphonuclear cells by alveolar macrophage-derived factor from lung cancer patients.

Authors:  A Vecchiarelli; M Dottorini; T Beccari; C Cociani; T Todisco; F Bistoni
Journal:  Am Rev Respir Dis       Date:  1993-02

2.  Murine natural killer cells are fungicidal to Cryptococcus neoformans.

Authors:  M R Hidore; N Nabavi; F Sonleitner; J W Murphy
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

3.  Neutrophils from patients with advanced human immunodeficiency virus infection have impaired complement receptor function and preserved Fcgamma receptor function.

Authors:  C Monari; A Casadevall; D Pietrella; F Bistoni; A Vecchiarelli
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

4.  Clinical significance of neutrophil functional activity in HIV infection.

Authors:  D Gabrilovich; L Ivanova; L Serebrovskaya; G Shepeleva; V Pokrovsky
Journal:  Scand J Infect Dis       Date:  1994

5.  Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.

Authors:  J Mukherjee; L S Zuckier; M D Scharff; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

6.  Impairment of neutrophil antifungal activity against hyphae of Aspergillus fumigatus in children infected with human immunodeficiency virus.

Authors:  E Roilides; A Holmes; C Blake; P A Pizzo; T J Walsh
Journal:  J Infect Dis       Date:  1993-04       Impact factor: 5.226

7.  Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infection.

Authors:  A Vecchiarelli; M Dottorini; D Pietrella; C Monari; C Retini; T Todisco; F Bistoni
Journal:  Am J Respir Cell Mol Biol       Date:  1994-08       Impact factor: 6.914

8.  Depressed neutrophil superoxide production in human immunodeficiency virus infection.

Authors:  D L Pitrak; P M Bak; P DeMarais; R M Novak; B R Andersen
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

9.  Impaired interleukin 12 production in human immunodeficiency virus-infected patients.

Authors:  J Chehimi; S E Starr; I Frank; A D'Andrea; X Ma; R R MacGregor; J Sennelier; G Trinchieri
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

10.  Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.

Authors:  A D'Andrea; M Rengaraju; N M Valiante; J Chehimi; M Kubin; M Aste; S H Chan; M Kobayashi; D Young; E Nickbarg
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Phagocytic activity in human immunodeficiency virus type 1 infection.

Authors:  Agostino Pugliese; Valerio Vidotto; Tiziana Beltramo; Donato Torre
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

2.  Presence of antibodies to SSB/La is associated with decreased phagocytic efficiency of neutrophils in patients with systemic lupus erythematosus.

Authors:  Debasis Biswas; Amrita Mathias; Rajeshwar Dayal; Amita Aggarwal; Ramnath Misra; Sita Naik
Journal:  Clin Rheumatol       Date:  2007-11-06       Impact factor: 2.980

3.  Humoral response against Cryptococcus neoformans mannoprotein antigens in HIV-infected patients.

Authors:  L Pitzurra; S Perito; F Baldelli; F Bistoni; A Vecchiarelli
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

4.  Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans.

Authors:  Claudia Monari; Thomas R Kozel; Francesco Bistoni; Anna Vecchiarelli
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

5.  Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy.

Authors:  Vikram Mehraj; Mohammad-Ali Jenabian; Kishanda Vyboh; Jean-Pierre Routy
Journal:  Open AIDS J       Date:  2014-12-29

Review 6.  Interactions of HIV and Antiretroviral Therapy With Neutrophils and Platelets.

Authors:  Morris Madzime; Theresa M Rossouw; Annette J Theron; Ronald Anderson; Helen C Steel
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.